chemotherapy

Open Access
Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center
MADISON NICHOLS, ANAM KESARIA, HORACE J. SPENCER, HEATHER R. WILLIAMS, SANTANU SAMANTA and GARY D. LEWIS

Anticancer Research January 2024, 44 (1) 151-155; DOI: https://doi.org/10.21873/anticanres.16797
You have access
Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer
JOSEFINE BAUDREXL, SEBASTIAN PIETZKA, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE, ANDREAS SAKKAS, SPYRIDOULA DERKA and MARCEL EBELING

Anticancer Research January 2024, 44 (1) 267-286; DOI: https://doi.org/10.21873/anticanres.16810
You have access
Analysis of an Unselected Patient Cohort With Advanced Colorectal Carcinoma from a Maximum Care Center
XIN-WEN ZHANG, JUTTA MOHR, NIELS HALAMA and RONALD KOSCHNY

Anticancer Research December 2023, 43 (12) 5589-5596; DOI: https://doi.org/10.21873/anticanres.16761
Open Access
Non-thermal Acoustic Enhancement of Chemotherapeutic Effects of Cisplatin on Xenografted Cervical Cancer in Mice
SEUNG-SCHIK YOO, PERRY KATSARAKES, JASON GASHI, EVGENII KIM, HYUN-CHUL KIM and MARK BÖHLKE

Anticancer Research November 2023, 43 (11) 4793-4800; DOI: https://doi.org/10.21873/anticanres.16676
Open Access
Osteosarcoma Arising After Ewing Sarcoma or Vice Versa: A Report of 20 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS)
STEFAN S. BIELACK, CLAUDIA BLATTMANN, WOLF HASSENPFLUG, LEO KAGER, THOMAS KUHNE, MATTHIAS KEVRIC, PAUL-GERHARDT SCHLEGEL, VANESSA METTMANN, BENJAMIN SORG and STEFANIE HECKER-NOLTING

Anticancer Research November 2023, 43 (11) 4975-4981; DOI: https://doi.org/10.21873/anticanres.16696
Open Access
The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review
ANGELA TULK, RAJ WATSON and JENNIFER ERDRICH

Anticancer Research October 2023, 43 (10) 4263-4275; DOI: https://doi.org/10.21873/anticanres.16621
Open Access
High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
TAKASHI HIGUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research October 2023, 43 (10) 4277-4284; DOI: https://doi.org/10.21873/anticanres.16622
You have access
RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression
HIROAKI NAGAMINE, MASAKAZU YASHIRO, NAOKI YOSHIMOTO, MOTOHIRO IZUMI, AKIRA SUGIMOTO, KENJI NAKAHAMA, KOICHI OGAWA, YOSHIYA MATSUMOTO, KENJI SAWA, YOKO TANI, HIROYASU KANEDA, SHIGEKI MITSUOKA, KAZUHIRO YAMADA, TETSUYA WATANABE, KAZUHISA AASAI, KAZUHIRO FUKUMURA, AKILA MAYEDA and TOMOYA KAWAGUCHI

Anticancer Research October 2023, 43 (10) 4663-4672; DOI: https://doi.org/10.21873/anticanres.16662
You have access
Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data
MAYAKO UCHIDA, SHIGERU ISHIDA, ERIKA MOCHIZUKI, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI and ICHIRO IEIRI

Anticancer Research September 2023, 43 (9) 4067-4075; DOI: https://doi.org/10.21873/anticanres.16596
You have access
Primary Synovial Sarcoma of the Bone: A Case Report and Literature Review
JIRO ICHIKAWA, TOMONORI KAWASAKI, HIROKI IMADA, SATOSHI KANNO, GENKI OOKITA, NAOFUMI TANIGUCHI, TOMOYUKI ASHIZAWA, RIKITO TATSUNO, TAKAHIRO JYUBASHI and HIROTAKA HARO

Anticancer Research September 2023, 43 (9) 4241-4247; DOI: https://doi.org/10.21873/anticanres.16617

Main menu

User menu

Search

chemotherapy

Pages